Search Results 7001-7010 of 34714 for oral

  1. Multi-center ESG Randomized Interventional Trial (MERIT-Trial) - Mayo Clinic

    50 patients with type II diabetes mellitus on oral agents only with HgA1c ≤ 9; and; Obesity HTH, Obesity DM) and block randomized. No more than 50 ...

  2. De-escalated therapy improves quality of life following oropharynx cancer treatment - Mayo Clinic

    The Head and Neck Cancer Center at Mayo Clinic provides a unique multidisciplinary approach for oropharynx cancer. This efficient team approach brings ...

  3. Voriconazole (intravenous route) - Side effects & uses - Mayo Clinic

    Your doctor will give you or your child a few doses of this medicine until your condition improves, and then switch you to an oral medicine that works the same ...

  4. A Study of Effect of Different Biochemical Markers including Leptin and Spexin in Children Before and After Having Hypothalamus Surgery - Mayo Clinic

    Ongoing use of insulin, metformin, or oral hypoglycemic medications. Malabsorption disorders (celiac disease, cystic fibrosis, and inflammatory bowel ...

  5. Head and Neck Cancer Center - Doctors - Mayo Clinic

    outh care, Dental surgery, Oral appliance therapy, Cancer, Oral and throat cancer, Mouth cancer, Head and neck cancer, Facial deformity, Jaw tumors and ...

  6. Publications - Carolyn L. Kinney, M.D. - Mayo Clinic

    2019 Nov; 1(4):237-246. Driscoll SW, Robinson LR, Raddatz MM, Kinney CL. Is There Evidence of Gender Bias in the Oral Examination for Initial Certification by ...

  7. Black History Month: Ph.D. Student Shares Story of Belonging at Mayo Clinic - News Archive

    When I was ready to return to work and complete my oral qualifying exam for Ph.D. candidacy, she often checked in on me, offered listening ears and a ...

  8. Mitral valve regurgitation - Diagnosis and treatment - Mayo Clinic

    Learn more about the symptoms and treatment of this most common heart valve condition, which causes blood to leak backward in the heart.

  9. Study of INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma - Mayo Clinic

    eceived therapeutic oral or IV antibiotics within 2 weeks prior to Day 0;; History or current evidence of any condition, therapy or laboratory abnormality ...

  10. An Extension Study Monitoring the Safety of Patients with Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 - Mayo Clinic

    ... oral contraceptive pill or transdermal patch, spermicide and barrier [condoms], intrauterine device, implants for contraception, injections for ...